The WACC of Neurocrine Biosciences Inc (NBIX) is 7.6%.
| Range | Selected | |
| Cost of equity | 6.50% - 8.90% | 7.70% |
| Tax rate | 23.10% - 26.00% | 24.55% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 6.5% - 8.8% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.57 | 0.71 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.50% | 8.90% |
| Tax rate | 23.10% | 26.00% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 6.5% | 8.8% |
| Selected WACC | 7.6% | |